ENVISTA HOLDINGS CORPORATION
In the published model solve dated 2026-Q2, anchored at $23.95, ENVISTA HOLDINGS CORPORATION (NVST) is priced for +4.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
• Envista is a dental products company spanning implants, clear-aligner orthodontics, and everyday consumables, and it has now posted four straight quarters of growth across all of its major businesses. [Source: Envista Q1 2026 results, May 2026] • The clearest risk is operating leverage off a thin base: the trailing operating margin sits around 8.5%, so the recovery thesis depends on margins expanding from a low level rather than on a fortress profitability already in place. • Watch core growth
Is NVST overvalued? See what's priced in →
375 institutional managers reported holding NVST in 13F filings for the quarter ended 2026-03-31. 83 opened new positions that quarter. Held by BlackRock, Vanguard Group, Dimensional Fund Advisors, among others. On the short side, 12.1M shares were sold short as of the 2026-06-15 count, about 7% of shares outstanding (4.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
NVST's share count grew 1.7% over the past five years even with $228.30M spent on repurchases. It pays no dividend. Cash returned over the past three years: $228.30M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at NVST over the trailing three years: 2023: 9 buys totaling $417k; 2024: 2 buys totaling $907k. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
NVST's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | +0.8% | -25.2% |
| 2023-11-02 | -8.7% | +10.0% |
| 2024-02-16 | -8.5% | -11.4% |
| 2024-05-02 | +0.7% | -17.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
NVST's latest 8-K filings: 2026-09-17 (items 7.01); 2026-08-19 (items 5.02, 8.01, 9.01); 2026-08-05 (items 2.02, 7.01, 9.01); 2026-06-03 (items 5.02, 9.01); 2026-05-21 (items 5.07, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.